employee expenses. Expenses from research & development, and innovation In compliance to NSTDA’s guideline, the Company reported research and development, and innovation expenses at Baht 1.19 million
LABORATORY AND RESEARCH CENTER PUBLIC COMPANY LIMITED / ASIA MEDICAL AND AGRICULTURAL LABORATORY AND RESEARCH CENTER PUBLIC COMPANY LIMITED Common share IPO CHIN HUAY PUBLIC COMPANY LIMITED / CHIN HUAY
RESEARCH CENTER PUBLIC COMPANY LIMITED AMARIN: AMARIN CORPORATIONS PUBLIC COMPANY LIMITED AMATA: AMATA CORPORATION PUBLIC COMPANY LIMITED ANI: Asia Network International Public Company Limited AOT: AIRPORTS
feasibility study to invest in a company. The Company’s total liabilities as at December 31, 2018 amounted to Baht 222.38 million, Increased by Baht 57.70 million or 35.04% from those of Baht 164.68 million as
which follow the plan of transition of the company. However, the Company has increment of expenses from the previous year that was mainly from feasibility study of new projects which will generate
(IPO), Baht 17.94 million in trade and other receivables, Baht 7.18 million in inventories, Baht 7.12 million in property, plant and equipment, and Baht 150 million in deposit for feasibility study to
reviewed and changed the estimated useful lives of buildings, machinery and equipment in accordance with their conditions and the proper estimation of useful lives with reference to the Health Study Report
token involve high risks; investors may lose all investment money and should study information carefully and make investments according to own risk profile.” http://law.sec.or.th/content/4946/7987/1
risks; investors may lose all investment money and should study information carefully and make investments according to own risk profile.” http://law.sec.or.th/content/4946/7987/1#7987 สธ. 43/2565